Nasdaq Listed Biotechnology Companies Under $160M Market Cap
With Cash & Equivalents – Cash above Market Cap – Trading % of Cash
Download
the Excel File from Noble
This document is provided by NobleLSP, a division of Noble Capital Markets, Inc.
Financial data is sourced from CapitalIQ, and is up-to-date as of 5/18/2022.
No investment decision should be based upon the content of this document. You should always consult an investment professional and consider the risk and suitability of any investment.
Noble Capital Markets publishes research on the following companies contained in the document: Tonix Pharmaceuticals, Genprex, PDS Biotechnology, Axcella Health
The following research disclosures pertain to these companies :
“The Company in this report is a participant in the Company Sponsored Research Program (“CSRP”); Noble receives compensation from the Company for such participation. No part of the CSRP compensation was, is, or will be directly or indirectly related to any specific recommendations or views expressed by the analyst in this research report.”
“Noble intends to seek compensation for investment banking services and non-investment banking services (securities and non-securities related) within the next 3 months.”
Please refer to the most recent research report published on each company (linked above) for up-to-date company specific disclosures.